TCM gets more global acceptance
Recognizing the increasing role that traditional Chinese medicine has been playing in treating chronic diseases, United Kingdom-based pharmaceutical company AstraZeneca has strengthened its TCM capability and will further promote the internationalization of the industry.
On June 7, AstraZeneca, the China Association of Chinese Medicine, the China Health Promotion Foundation and People's Daily jointly launched a TCM project for cardiovascular and cerebrovascular health.
Specifically, the project aims to improve screening coverage of patients by boosting screening capabilities at both Chinese and Western medicine hospitals at multiple levels. It will also provide training programs for large hospitals and communities, as well as primary-care institutions such as township-level health centers, to help better take advantage of the integration of Chinese and Western medicine.